Πλοήγηση ανά Θέμα "interleukin 1"

Adrenocorticotropic hormone: an effective “natural” biologic therapy for acute gout?

Daoussis D., Bogdanos D.P., Dimitroulas T., Sakkas L., Andonopoulos A.P. (2020)

Treatment of acute gout consists of non-steroidal anti-inflammatory drugs (NSAIDs), colchicine and steroids. However, the typical patient with gout has multiple comorbidities such as cardiovascular disease, hypertension, ...

Breast radiotherapy and early adverse cardiac effects. The role of serum biomarkers and strain echocardiography

Gkantaifi A., Papadopoulos C., Spyropoulou D., Toumpourleka M., Iliadis G., Kardamakis D., Nikolaou M., Tsoukalas N., Kyrgias G., Tolia M. (2019)

Breast cancer radiotherapy has a clear benefit for both long-term survival and local recurrence rate. However, there is still much concern about the early radiation-induced heart toxicity. This article aimed to clarify the ...

Cytokines and pathological sleep

Kapsimalis, F.; Basta, M.; Varouchakis, G.; Gourgoulianis, K.; Vgontzas, A.; Kryger, M. (2008)

Cytokines are proteins produced by leukocytes and other cells that function as intercellular mediators acting on several target tissues, resulting in multiple biologic actions. Over the last decade, medical research has ...

Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review

Tziastoudi M., Cholevas C., Stefanidis I., Theoharides T.C. (2022)

COVID-19 and ME/CFS present with some similar symptoms, especially physical and mental fatigue. In order to understand the basis of these similarities and the possibility of underlying common genetic components, we performed ...

IL-1 cytokines in cardiovascular disease: Diagnostic, prognostic and therapeutic implications

Apostolakis, S.; Vogiatzi, K.; Krambovitis, E.; Spandidos, D. A. (2008)

Interleukins (ILs) are key mediators in the chronic vascular inflammatory response underlying several aspects of cardiovascular disease. Due to their powerful pro-inflammatory potential, and the fact that they are highly ...

The IL-1 inhibitor Canakinumab for Familial Mediterranean Fever: The Greek experience in 12 patients

Laskari K., Boura P., Dalekos G.N., Garyfallos A., Karokis D., Pikazis D., Settas L., Skarantavos G., Tsitsami E., Sfikakis P.P. (2015)

[No abstract available]

Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials

Grammatikopoulou M.G., Tousinas G., Balodimou C., Anastasilakis D.A., Gkiouras K., Dardiotis E., Evangeliou A.E., Bogdanos D.P., Goulis D.G. (2022)

Objective: The aim of the present systematic review was to assess the efficacy of ketogenic therapy in Parkinson's disease (PD), using all available data from randomized controlled trials (RCTs) on humans and animal studies ...